Context Therapeutics Inc (CNTX)
2.25
-0.02
(-0.88%)
USD |
NASDAQ |
Nov 04, 13:11
Context Therapeutics 1 Year Total Returns (Daily): 104.5% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 104.5% |
October 31, 2024 | 105.7% |
October 30, 2024 | 110.7% |
October 29, 2024 | 121.8% |
October 28, 2024 | 127.7% |
October 25, 2024 | 120.8% |
October 24, 2024 | 88.00% |
October 23, 2024 | 102.7% |
October 22, 2024 | 76.99% |
October 21, 2024 | 82.30% |
October 18, 2024 | 59.38% |
October 17, 2024 | 55.81% |
October 16, 2024 | 58.91% |
October 15, 2024 | 51.16% |
October 14, 2024 | 54.26% |
October 11, 2024 | 46.27% |
October 10, 2024 | 28.57% |
October 09, 2024 | 38.35% |
October 08, 2024 | 37.78% |
October 07, 2024 | 35.56% |
October 04, 2024 | 64.31% |
October 03, 2024 | 42.45% |
October 02, 2024 | 34.04% |
October 01, 2024 | 23.18% |
September 30, 2024 | 29.80% |
Date | Value |
---|---|
September 27, 2024 | 44.19% |
September 26, 2024 | 66.67% |
September 25, 2024 | 103.2% |
September 24, 2024 | 90.29% |
September 23, 2024 | 101.9% |
September 20, 2024 | 151.1% |
September 19, 2024 | 137.2% |
September 18, 2024 | 107.1% |
September 17, 2024 | 115.5% |
September 16, 2024 | 115.5% |
September 13, 2024 | 104.9% |
September 12, 2024 | 104.8% |
September 11, 2024 | 98.15% |
September 10, 2024 | 136.7% |
September 09, 2024 | 137.8% |
September 06, 2024 | 130.8% |
September 05, 2024 | 131.5% |
September 04, 2024 | 143.0% |
September 03, 2024 | 145.0% |
August 30, 2024 | 127.9% |
August 29, 2024 | 117.8% |
August 28, 2024 | 125.9% |
August 27, 2024 | 150.0% |
August 26, 2024 | 150.0% |
August 23, 2024 | 141.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-86.74%
Minimum
Dec 09 2022
266.2%
Maximum
May 17 2024
11.98%
Average
-9.78%
Median
1 Year Total Returns (Daily) Benchmarks
Collegium Pharmaceutical Inc | 53.49% |
NovaBay Pharmaceuticals Inc | -93.74% |
Palatin Technologies Inc | -43.13% |
iBio Inc | -49.85% |
Theriva Biologics Inc | -82.11% |